{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:33:13Z","timestamp":1794339193302,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac sarcoidosis (CS) and giant cell myocarditis (GCM) are rare diseases that share some similarities, but also display different clinical and histopathological features. We aimed to compare the demographics, clinical presentation, and outcome of patients diagnosed with CS or GCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We compared the clinical data and outcome of all adult patients with CS (n\u2009=\u200971) or GCM (n\u2009=\u200921) diagnosed at our center between 1991 and 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median (interquartile range) follow-up time for patients with CS and GCM was 33.5 [6.5\u201360.9] and 2.98 [0.6\u201340.9] months, respectively. In the entire cohort, heart failure (HF) was the most common presenting manifestation (31%), followed by ventricular arrhythmias (25%). At presentation, a left ventricular ejection fraction of\u2009&lt;\u200950% was found in 54% of the CS compared to 86% of the GCM patients (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014), while corresponding proportions for right ventricular dysfunction were 24% and 52% (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026), respectively. Advanced HF (NYHA\u2009\u2265\u2009IIIB) was less common in CS (31%) than in GCM (76%). CS patients displayed significantly lower circulating levels of natriuretic peptides (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and troponins (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014). Eighteen percent of patients with CS included in the survival analysis reached the composite endpoint of death or heart transplantation (HTx) compared to 68% of patients with GCM (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GCM has a more fulminant clinical course than CS with severe biventricular failure, higher levels of circulating biomarkers and an increased need for HTx. The histopathologic diagnosis remained key determinant even after adjustment for markers of cardiac dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-022-02639-0","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T09:12:52Z","timestamp":1650964372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience"],"prefix":"10.1186","volume":"22","author":[{"given":"Emanuele","family":"Bobbio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Hjalmarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bj\u00f6rkenstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Polte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Oldfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Dahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Erik","family":"Bartfay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Szamlewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidija","family":"Sakiniene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristjan","family":"Karason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Entela","family":"Bollano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"2639_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10741-012-9358-3","volume":"18","author":"LA Blauwet","year":"2013","unstructured":"Blauwet LA, Cooper LT. Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev. 2013;18:733\u201346.","journal-title":"Heart Fail Rev"},{"key":"2639_CR2","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13:e007405.","journal-title":"Circ Heart Fail"},{"key":"2639_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00392-021-01920-0","volume":"111","author":"E Bobbio","year":"2021","unstructured":"Bobbio E, Bjorkenstam M, Nwaru BI, Giallauria F, Hessman E, Bergh N, et al. Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis. Clin Res Cardiol. 2021;111:125\u201340.","journal-title":"Clin Res Cardiol"},{"key":"2639_CR4","first-page":"1126","volume":"9","author":"SH Litovsky","year":"1996","unstructured":"Litovsky SH, Burke AP, Virmani R. Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells. Mod Pathol. 1996;9:1126\u201334.","journal-title":"Mod Pathol"},{"key":"2639_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","volume":"21","author":"O Leone","year":"2012","unstructured":"Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol. 2012;21:245\u201374.","journal-title":"Cardiovasc Pathol"},{"key":"2639_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/CIRCRESAHA.117.310221","volume":"121","author":"BH Trachtenberg","year":"2017","unstructured":"Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. Circ Res. 2017;121:803\u201318.","journal-title":"Circ Res"},{"key":"2639_CR7","doi-asserted-by":"publisher","first-page":"e019415","DOI":"10.1161\/JAHA.120.019415","volume":"10","author":"HK Nordenswan","year":"2021","unstructured":"Nordenswan HK, Lehtonen J, Ekstrom K, Raisanen-Sokolowski A, Mayranpaa MI, Vihinen T, et al. Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25-year nationwide cohorts. J Am Heart Assoc. 2021;10:e019415.","journal-title":"J Am Heart Assoc"},{"key":"2639_CR8","doi-asserted-by":"publisher","first-page":"e020542","DOI":"10.1161\/JAHA.121.020542","volume":"10","author":"DH Birnie","year":"2021","unstructured":"Birnie DH, Nair V, Veinot JP. Cardiac sarcoidosis and giant cell myocarditis: actually, 2 ends of the same disease? J Am Heart Assoc. 2021;10:e020542.","journal-title":"J Am Heart Assoc"},{"key":"2639_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/2040622318790197","volume":"9","author":"EV Arkema","year":"2018","unstructured":"Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis. 2018;9:227\u201340.","journal-title":"Ther Adv Chronic Dis"},{"key":"2639_CR10","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","volume":"48","author":"EV Arkema","year":"2016","unstructured":"Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J. 2016;48:1690\u20139.","journal-title":"Eur Respir J"},{"key":"2639_CR11","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305\u201323.","journal-title":"Heart Rhythm"},{"key":"2639_CR12","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1136\/hrt.2011.226076","volume":"97","author":"G Youssef","year":"2011","unstructured":"Youssef G, Beanlands RS, Birnie DH, Nery PB. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart. 2011;97:2078\u201387.","journal-title":"Heart"},{"key":"2639_CR13","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis- digest version. Circ J. 2019;83:2329\u201388.","journal-title":"Circ J"},{"key":"2639_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","volume":"270","author":"R Kandolin","year":"2011","unstructured":"Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivisto SM, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270:461\u20138.","journal-title":"J Intern Med"},{"key":"2639_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","volume":"157","author":"JS Kim","year":"2009","unstructured":"Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J. 2009;157:9\u201321.","journal-title":"Am Heart J"},{"key":"2639_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","volume":"41","author":"Y Okura","year":"2003","unstructured":"Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41:322\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2639_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"key":"2639_CR18","unstructured":"Authors\/Task Force M, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24:4\u2013131."},{"key":"2639_CR19","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1002\/ehf2.13448","volume":"8","author":"O Bech-Hanssen","year":"2021","unstructured":"Bech-Hanssen O, Astengo M, Fredholm M, Bergh N, Hjalmarsson C, Polte CL, et al. Grading right ventricular dysfunction in left ventricular disease using echocardiography: a proof of concept using a novel multiparameter strategy. ESC Heart Fail. 2021;8:3223\u201336.","journal-title":"ESC Heart Fail"},{"key":"2639_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ejhf.1029","volume":"20","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20:16\u201337.","journal-title":"Eur J Heart Fail"},{"key":"2639_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/diagnostics12020399","volume":"12","author":"CL Polte","year":"2022","unstructured":"Polte CL, Bobbio E, Bollano E, Bergh N, Polte C, Himmelman J, et al. Cardiovascular magnetic resonance in myocarditis. Diagnostics. 2022;12:399.","journal-title":"Diagnostics"},{"key":"2639_CR22","doi-asserted-by":"crossref","unstructured":"Bobbio E, Karason K. Myocarditis and Inflammatory Cardiomyopathy In: IntechOpen, editor. Cardiomyopathy\u2014disease of the heart muscle. IntechOpen; 2021.","DOI":"10.5772\/intechopen.98998"},{"key":"2639_CR23","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/ehf2.12725","volume":"7","author":"K Ekstrom","year":"2020","unstructured":"Ekstrom K, Raisanen-Sokolowski A, Lehtonen J, Nordenswan HK, Mayranpaa MI, Kupari M. Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series. ESC Heart Fail. 2020;7:1362\u201370.","journal-title":"ESC Heart Fail"},{"key":"2639_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/hrt.37.2.192","volume":"37","author":"MJ Davies","year":"1975","unstructured":"Davies MJ, Pomerance A, Teare RD. Idiopathic giant cell myocarditis: a distinctive clinico-pathological entity. Br Heart J. 1975;37:192\u20135.","journal-title":"Br Heart J"},{"key":"2639_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jccase.2013.09.004","volume":"9","author":"K Nakasuka","year":"2014","unstructured":"Nakasuka K, Ito S, Miyata K, Inomata M, Yoshida T, Tamai N, et al. A case of idiopathic giant cell myocarditis with a past history of sarcoidosis. J Cardiol Cases. 2014;9:35\u20139.","journal-title":"J Cardiol Cases"},{"key":"2639_CR26","doi-asserted-by":"publisher","first-page":"e2020238","DOI":"10.4322\/acr.2020.238","volume":"10","author":"JP Ziegler","year":"2020","unstructured":"Ziegler JP, Batalis NI, Fulcher JW, Ward ME. Giant cell myocarditis causing sudden death in a patient with sarcoidosis. Autops Case Rep. 2020;10:e2020238.","journal-title":"Autops Case Rep"},{"key":"2639_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","volume":"63","author":"WC Roberts","year":"1977","unstructured":"Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63:86\u2013108.","journal-title":"Am J Med"},{"key":"2639_CR28","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","volume":"13","author":"AR Patel","year":"2011","unstructured":"Patel AR, Klein MR, Chandra S, Spencer KT, Decara JM, Lang RM, et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail. 2011;13:1231\u20137.","journal-title":"Eur J Heart Fail"},{"key":"2639_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","volume":"120","author":"MR Patel","year":"2009","unstructured":"Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969\u201377.","journal-title":"Circulation"},{"key":"2639_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0002-9149(98)00377-4","volume":"82","author":"Y Yazaki","year":"1998","unstructured":"Yazaki Y, Isobe M, Hiramitsu S, Morimoto S, Hiroe M, Omichi C, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82:537\u201340.","journal-title":"Am J Cardiol"},{"key":"2639_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/eci.12.10","volume":"8","author":"D Fairweather","year":"2012","unstructured":"Fairweather D, Petri MA, Coronado MJ, Cooper LT. Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol. 2012;8:269\u201384.","journal-title":"Expert Rev Clin Immunol"},{"key":"2639_CR32","doi-asserted-by":"publisher","first-page":"e008968","DOI":"10.1161\/JAHA.118.008968","volume":"8","author":"MJ Coronado","year":"2019","unstructured":"Coronado MJ, Bruno KA, Blauwet LA, Tsch\u00f6pe C, Cunningham MW, Pankuweit S, et al. Elevated sera sST2 is associated with heart failure in men \u226450 years old with myocarditis. J Am Heart Assoc. 2019;8:e008968.","journal-title":"J Am Heart Assoc"},{"key":"2639_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","volume":"104","author":"F Tavora","year":"2009","unstructured":"Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol. 2009;104:571\u20137.","journal-title":"Am J Cardiol"},{"key":"2639_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624\u201332.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02639-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02639-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02639-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T09:59:59Z","timestamp":1675418399000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02639-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2639"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02639-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study conforms to the principles outlined in the Declaration of Helsinki and was approved by the Ethic Review Authority in Gothenburg (Approval No. 2019-05401). The inform consent was waived by Ethic Review Authority in Gothenburg.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}